Actus Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
Actus Therapeutics General Information
Description
Developer of new therapies intended for rare genetic childhood and adult-onset diseases. The company's therapies addresses glycogen storage disorder by using targeted and low dose method, enabling patients to access treatment at a lower effective dose and with more cell type specificity and less potential systemic effects than other adeno-associated virus vectors.
Contact Information
Website
www.actustherapeutics.comCorporate Office
- 870 Martin Luther King Junior Boulevard
- NC 27514
- United States
Corporate Office
- 870 Martin Luther King Junior Boulevard
- NC 27514
- United States
Actus Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Actus Therapeutics Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Josh Greiger Ph.D | Chief Technology Officer | |
| Philippe Moullier Ph.D | Co-Founder & Chief Scientific Officer |
Actus Therapeutics FAQs
-
When was Actus Therapeutics founded?
Actus Therapeutics was founded in 2017.
-
Who is the founder of Actus Therapeutics?
Philippe Moullier Ph.D is the founder of Actus Therapeutics.
-
Where is Actus Therapeutics headquartered?
Actus Therapeutics is headquartered in NC.
-
What industry is Actus Therapeutics in?
Actus Therapeutics’s primary industry is Biotechnology.
-
Is Actus Therapeutics a private or public company?
Actus Therapeutics is a Private company.
-
What is Actus Therapeutics’s current revenue?
The current revenue for Actus Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
